as 03-28-2025 4:00pm EST
Founded: | 1944 | Country: | United States |
Employees: | N/A | City: | INDIANAPOLIS |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $530.83 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Buy | Number of Analysts: | 15 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 25.68 | EPS Growth: | 1.82 |
52 Week Low/High: | $362.21 - $567.26 | Next Earning Date: | 04-17-2025 |
Revenue: | $176,810,000,000 | Revenue Growth: | 3.19% |
Revenue Growth (this year): | 10.11% | Revenue Growth (next year): | 7.27% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Penczek Ronald W | ELV | CAO & Controller | Mar 10 '25 | Sell | $415.13 | 443 | $183,902.59 | 1,847 | |
Kendrick Charles Morgan JR | ELV | EVP & President, Commercial | Mar 3 '25 | Sell | $396.30 | 3,504 | $1,388,635.20 | 10,116 |
ELV Breaking Stock News: Dive into ELV Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
MT Newswires
a day ago
Zacks
2 days ago
Morningstar Research
3 days ago
Simply Wall St.
5 days ago
Insider Monkey
6 days ago
Zacks
11 days ago
Zacks
11 days ago
The information presented on this page, "ELV Elevance Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.